Found 0 matching trials
CART-19 Cells for R/R B-cell Lymphoma PHASE2 Relapsed/Refractory B Cell Lymphoma is a challenge to be treated, however,C...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial
CART-19 Post-ASCT for Multiple Myeloma PHASE2 This will be a single-arm, open-label study. Patients will be enrolled duri...
Show More Location
Abramson Cancer Center of the University of Pennsylvania
Learn More & Join Trial
CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies PHASE1 This phase I clinical trial studies the side effects and best dose of CD19-...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma PHASE1 Phase I Dose Escalation Study of CART19 Cells for Adult Patients With Relap...
Show More Location
Institute of Hematology and Blood Transfusion, Czech Republic
Learn More & Join Trial
Mitoxantrone Hydrochloride Liposome Injection-containing Bridging Regimen and CD19-targeting CAR-T Therapies PHASE2 The goal of this open, single-arm practical, phase II, clinical study is to...
Show More Status
Active Not Recruiting
Location
Union Hospital, Huazhong University of Science and Technology
Learn More & Join Trial
Duvelisib Exposure to Enhance Immune Profiles of T Cells in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma, DEEP T CELLS Study EARLY_PHASE1 This early phase I trial investigates how well duvelisib exposure before CA...
Show More Location
Emory University Hospital/Winship Cancer Institute
Learn More & Join Trial
CART19 in Adult Patients With Minimal Residual Disease During Upfront Treatment for ALL PHASE2 This is a single center, single arm, open-label phase 2 study to determine ...
Show More Location
University of Pennsylvania
Learn More & Join Trial
Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients PHASE2 This is a multi-center, phase II study to determine the efficacy and safety...
Show More Location
UCSF Medical Center .
Learn More & Join Trial
Pilot Study of Redirected Autologous T Cells Engineered to Contain Humanized Anti-CD19 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma Previously Treated With Cell Therapy PHASE1 This is a pilot study to evaluate humanized CD19 redirected autologous T ce...
Show More Location
Children's Hospital of Philadelphia
Learn More & Join Trial
The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL). PHASE1 This is a study for patients who have been previously treated for B-ALL. Th...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial